Global Lyme Disease Diagnostic Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 132
Status: Published
Report Code: ARI101031
The Lyme disease diagnostic industry is booming, because to reasons like rising Lyme disease prevalence and the introduction of new Lyme diagnostic tests. The bacterium borrelia burgdorferi causes Lyme disease, which is transmitted to humans by the bite of an infected blacklegged deer tick. Antibodies to B. burgdorferi can be detected using a variety of tests, including the ELISA test. If the ELISA test is positive, a Western blot test is performed to look for B. burgdorferi proteins. Furthermore, the rising number of cases of tick-borne infections is propelling the Lyme disease diagnostic market forward.
The market is driven by the rising frequency of Lyme disease, the government's increased focus on improving healthcare facilities, and the emergence of novel Lyme disease diagnostic tests. However, the market is severely constrained by a lack of awareness about the disease and ineffective Lyme disease testing. Furthermore, the market is expected to benefit from an increase in key players' interest in Lyme disease diagnosis research and development The global Lyme disease diagnostics market is segmented by emerging diagnostic technology and end user, according to the report. The market is divided into serological tests (ELISA and Western Blot), urine antigen tests, lymphocytic transformation test, immunofluorescent staining, nucleic acid test, and others based on diagnostic technology. The market is divided into hospitals, public/private laboratories, and physicians' offices, depending on the end user. It is divided into four regions: North America, Europe, Asia-Pacific, and LAMEA.
Lyme disease is a type of bacterial infection that affects humans. Diagnostic tests are used to diagnose signs and symptoms, as well as other disorders, such as Lyme Disease-related neurologic and cardiac issues. Antibodies formed by the immune system in response to the contamination are discovered during these diagnostic tests. Lyme Disease Diagnostics forecasts whether or not the sick person will be exposed to infected blacklegged ticks.
The report digs into the worldwide Lyme disease diagnostic market's competitive landscape. The global Lyme disease diagnostic market's key players are identified, and each one is profiled in terms of several aspects. Players in the global Lyme disease diagnostic market are profiled in this study based on their company overview, financial standings, latest advancements, and SWOT analysis.
As the number of instances of tick-borne infections rises, so does the demand for Lyme disease diagnostics. The Centers for Disease Control and Prevention (CDC) recommends two procedures for identifying these immunizers or antibodies and confirming a Lyme disease diagnosis. A novel, rapid point-of-care Lyme diagnostic test based on lateral flow technology is being developed by a group of researchers.
The study examines the global Lyme disease diagnostics market in full, including current trends and future projections, in order to identify potential investment opportunities.
Table of Contents
Chapter 1 Executive Summary 15
1.1 Global Lyme Disease Diagnostic Market: Executive Summary 15
1.1.1 Global Lyme Disease Diagnostic Market Revenue, 2015-2028 (USD Million) 16
Chapter 2 Research Methodology 17
2.1 Methodology/Research Approach 17
2.1.1 Research Programs/Design 17
2.1.2 Market Size Estimation 18
2.2 Data Source 18
2.2.1 Secondary Sources 18
2.2.1.1 Preliminary data mining 19
2.2.2 Primary Sources 19
2.2.2.1 Data Collection Matrix 21
2.2.3 Statistical model 21
2.2.4 Data Triangulation 22
2.2.5 Report Objectives 22
Chapter 3 Market Outlook 23
3.1 Trend 23
3.1.1 In the Lyme Disease Diagnostic Market, the serological test segment is expected to increase at the fastest rate 23
3.2 Driver 23
3.2.1 The increasing awareness about the novel techniques to diagnose Lyme disease 23
3.2.2 Identifying techniques of chronic Lyme infection from blood sample 23
3.3 Restraint 24
3.4 Opportunity 24
3.4.1 Identifying techniques of chronic Lyme infection from a blood sample 24
3.5 Challenges 24
3.5.1 For community physicians practicing in high-risk geographic areas 24
3.6 Impact Analysis of Driver, Restraint, Opportunity and Challenge 25
3.7 Porter’s Five Forces Analysis 26
3.7.1 Bargaining Power of Suppliers: Moderate to High 26
3.7.2 Bargaining Power of Buyers: Low to Moderate 27
3.7.3 Threat of New Entrants: High 28
3.7.4 Threat of Substitutes: Moderate to High 29
3.7.5 Competitive Rivalry: Moderate 30
3.8 Value Chain Analysis 31
Chapter 4 Impact of COVID-19 on Lyme Disease Diagnostic Market 32
Chapter 5 Global Lyme Disease Diagnostic Market Overview, By Diagnostic Technology 2015 - 2028 33
5.1 Global Lyme Disease Diagnostic Market Revenue Share, By Diagnostic Technology, 2015, 2021 and 2028 (%) 33
5.2 Global Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 34
5.2.1 Serological test 35
5.2.1.1 Introduction 35
5.2.1.2 Global Lyme Disease Diagnostic Market Revenue, by Serological test, By Diagnostic Technology,2015-2028 (USD Million) 36
5.2.1.3 Global Lyme Disease Diagnostic Market Revenue, by Serological test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 37
5.2.2 Lymphocytic transformation test 38
5.2.2.1 Introduction 38
5.2.2.2 Global Lyme Disease Diagnostic Market Revenue, by Lymphocytic transformation test, By Diagnostic Technology,2015-2028 (USD Million) 39
5.2.2.3 Global Lyme Disease Diagnostic Market Revenue, by Lymphocytic transformation test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 40
5.2.3 Urine Antigen Testing 41
5.2.3.1 Introduction 41
5.2.3.2 Global Lyme Disease Diagnostic Market Revenue, by Urine Antigen Testing, By Diagnostic Technology,2015-2028 (USD Million) 42
5.2.3.3 Global Lyme Disease Diagnostic Market Revenue, by Urine Antigen Testing, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 43
5.2.4 Immunofluorescent staining 44
5.2.4.1 Introduction 44
5.2.4.2 Global Lyme Disease Diagnostic Market Revenue, by Immunofluorescent staining, By Diagnostic Technology,2015-2028 (USD Million) 45
5.2.4.3 Global Lyme Disease Diagnostic Market Revenue, by Immunofluorescent staining, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 46
5.2.5 Nucleic acid test 47
5.2.5.1 Introduction 47
5.2.5.2 Global Lyme Disease Diagnostic Market Revenue, by Nucleic acid test, By Diagnostic Technology,2015-2028 (USD Million) 48
5.2.5.3 Global Lyme Disease Diagnostic Market Revenue, by Nucleic acid test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 49
Chapter 6 Global Lyme Disease Diagnostic Market Overview, By End User, 2015 - 2028 50
6.1 Global Lyme Disease Diagnostic Market Revenue Share, By End User, 2021 and 2028 (%) 50
6.2 Global Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 51
6.2.1 Hospitals 52
6.2.1.1 Introduction 52
6.2.1.2 Global Lyme Disease Diagnostic Market Revenue, by Hospitals, By End User,2015-2028 (USD Million) 53
6.2.1.3 Global Lyme Disease Diagnostic Market Revenue, by Hospitals, By End User, by Region, 2015-2028 (USD Million) 54
6.2.2 Clinical Laboratories 55
6.2.2.1 Introduction 55
6.2.2.2 Global Lyme Disease Diagnostic Market Revenue, by Clinical Laboratories, By End User,2015-2028 (USD Million) 56
6.2.2.3 Global Lyme Disease Diagnostic Market Revenue, by Clinical Laboratories, By End User, by Region, 2015-2028 (USD Million) 57
Chapter 7 Global Lyme Disease Diagnostic Market Overview, By Geography, 2015 - 2028 58
7.1 Global Lyme Disease Diagnostic Market Revenue Share, By Geographic Regions, 2021 & 2028 (%) 58
7.2 Global Lyme Disease Diagnostic Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 59
Chapter 8 North America Lyme Disease Diagnostic Market Overview, By Countries 60
8.1 North America Lyme Disease Diagnostic Market Overview, 2015 - 2028 60
8.1.1 Introduction 60
8.2 North America Lyme Disease Diagnostic Market Revenue, 2015 & 2028 61
8.2.1 North America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 62
8.2.2 North America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 62
8.2.3 North America Lyme Disease Diagnostic Market Revenue Share, By Countries Analysis, 2015 - 2028 63
8.2.4 North America Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 64
8.2.4.1.1 US Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 65
8.2.4.1.2 US Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 65
8.2.4.1.3 Canada Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 66
8.2.4.1.4 Canada Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 66
8.2.4.1.5 Mexico Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 67
8.2.4.1.6 Mexico Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 67
Chapter 9 Europe Lyme Disease Diagnostic Market Overview, By Countries 68
9.1 Europe Lyme Disease Diagnostic Market Overview, 2015 - 2028 68
9.1.1 Introduction 68
9.2 Europe Lyme Disease Diagnostic Market Revenue, 2015 & 2028 69
9.2.1 Europe Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 70
9.2.2 Europe Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 70
9.2.3 Europe Lyme Disease Diagnostic Market Revenue Share, By Countries Analysis, 2021 & 2028 (%) 71
9.2.4 Europe Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 72
9.2.4.1.1 Germany Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 73
9.2.4.1.2 Germany Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 73
9.2.4.1.3 UK Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 74
9.2.4.1.4 UK Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 74
9.2.4.1.5 France Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 75
9.2.4.1.6 France Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 75
9.2.4.1.7 Italy Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 76
9.2.4.1.8 Italy Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 76
9.2.4.1.9 Spain Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 77
9.2.4.1.10 Spain Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 77
9.2.4.1.11 Rest of Europe Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 78
9.2.4.1.12 Rest of Europe Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 78
Chapter 10 Asia Pacific Lyme Disease Diagnostic Market Overview, By Countries 79
10.1 Asia Pacific Lyme Disease Diagnostic Market Overview, 2015 - 2028 (USD Million) 79
10.1.1 Introduction 79
10.2 Asia Pacific Lyme Disease Diagnostic Market Revenue, 2015 - 2028 80
10.2.1 Asia Pacific Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 81
10.2.2 Asia Pacific Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 81
10.2.3 Asia Pacific Lyme Disease Diagnostic Market Revenue Share, By Countries Analysis, 2021 & 2028 (%) 82
10.2.4 Asia Pacific Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 83
10.2.4.1 China Lyme Disease Diagnostic Market By Diagnostic Technology, 2015 - 2028 84
10.2.4.2 China Lyme Disease Diagnostic Market, By End User, 2015 - 2028 84
10.2.4.3 India Lyme Disease Diagnostic Market By Diagnostic Technology, 2015 - 2028 85
10.2.4.4 India Lyme Disease Diagnostic Market, By End User, 2015 - 2028 85
10.2.4.5 Japan Lyme Disease Diagnostic Market By Diagnostic Technology, 2015 - 2028 86
10.2.4.6 Japan Lyme Disease Diagnostic Market, By End User, 2015 - 2028 86
10.2.4.7 South Korea Lyme Disease Diagnostic Market By Diagnostic Technology, 2015 - 2028 87
10.2.4.8 South Korea Lyme Disease Diagnostic Market, By End User, 2015 - 2028 87
10.2.4.9 Rest of Asia-Pacific Lyme Disease Diagnostic Market By Diagnostic Technology, 2015 - 2028 88
10.2.4.10 Rest of Asia-Pacific Lyme Disease Diagnostic Market, By End User, 2015 - 2028 88
Chapter 11 Middle East & Africa Lyme Disease Diagnostic Market Overview, By Countries 89
11.1 Middle East & Africa Lyme Disease Diagnostic Market Overview, 2015 - 2028 (USD Million) 89
11.1.1 Introduction 89
11.2 Middle East & Africa Lyme Disease Diagnostic Market Revenue, 2015 - 2028 90
11.2.1 Middle East & Africa Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 91
11.2.2 Middle East & Africa Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 91
11.2.3 Middle East & Africa Lyme Disease Diagnostic Market Revenue Share, By Countries Analysis, 2021 & 2028 (%) 92
11.2.4 Middle East & Africa Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 93
11.2.5 GCC Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 94
11.2.6 GCC Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 94
11.2.7 South Africa Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 95
11.2.8 South Africa Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 95
11.2.9 ROMEA Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 96
11.2.10 ROMEA Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 96
Chapter 12 South America Lyme Disease Diagnostic Market Overview, By Countries 97
12.1 South America Lyme Disease Diagnostic Market Overview, 2015 - 2028 (USD Million) 97
12.1.1 Introduction 97
12.2 South America Lyme Disease Diagnostic Market Revenue, 2015 - 2028 98
12.2.1 South America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 99
12.2.2 South America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 99
12.2.3 South America Lyme Disease Diagnostic Market Revenue Share, By Countries Analysis, 2021 & 2028 100
12.2.4 South America Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 101
12.2.5 Brazil Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 102
12.2.6 Brazil Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 102
12.2.7 Argentina Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 103
12.2.8 Argentina Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 103
12.2.9 Rest of South America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 104
12.2.10 Rest of South America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 104
Chapter 13 Competitive Landscape 105
13.1 Competitive Environment, 2021 105
13.2 Strategic Framework 106
13.2.1 Recent Initiatives 106
Chapter 14 Key Vendor Analysis 107
14.1 Bio-Rad Laboratories 107
14.1.1 Company Basic information 107
14.1.2 Company Profile: 107
14.1.3 Financial Overview(USD Billion): 108
14.1.4 Product Benchmarking 108
14.1.5 Recent Developments 108
14.1.6 SWOT Analysis 108
14.2 T2 Biosystems 110
14.2.1 Company Basic information 110
14.2.2 Company Profile: 110
14.2.3 Financial Overview(USD Million): 111
14.2.4 Product Benchmarking 111
14.2.5 Recent Developments 111
14.2.6 SWOT Analysis 111
14.3 Oxford Immunotec 113
14.3.1 Company Basic information 113
14.3.2 Company Profile: 113
14.3.3 Financial Overview(USD Million): 114
14.3.4 Product Benchmarking 114
14.3.5 Recent Developments 114
14.3.6 SWOT Analysis 114
14.4 Roche Diagnostics International Ltd 115
14.4.1 Company Basic information 115
14.4.2 Company Profile: 115
14.4.3 Product Benchmarking 116
14.4.4 Recent Developments 116
14.4.5 SWOT Analysis 116
14.5 Abbott Laboratories 118
14.5.1 Company Basic information 118
14.5.2 Company Profile: 118
14.5.3 Financial Overview(USD Billion): 119
14.5.4 Product Benchmarking 119
14.5.5 Recent Developments 119
14.5.6 SWOT Analysis 119
14.6 Canon Life Sciences 121
14.6.1 Company Basic information 121
14.6.2 Company Profile: 121
14.6.3 Financial Overview 122
14.6.4 Product Benchmarking 122
14.6.5 Recent Developments 122
14.6.6 SWOT Analysis 122
14.7 Labcorp Drug Development 123
14.7.1 Company Basic information 123
14.7.2 Company Profile: 123
14.7.3 Financial Overview(USD Billion): 124
14.7.4 Product Benchmarking 124
14.7.5 Recent Developments 124
14.7.6 SWOT Analysis 125
Chapter 15 Marketing Strategy Analysis, Distributors/Traders 126
15.1 Marketing Channel 126
15.1.1 Direct Marketing 126
15.1.2 Indirect Marketing 126
15.2 Market Positioning 127
15.2.1 Pricing Strategy 127
15.2.2 Brand Strategy 127
15.2.3 Target Client 127
Chapter 16 Market Effect Factors Analysis 128
16.1 Future Possibilities for Diagnostic Tools 128
16.2 New Research and Approches 128
Chapter 17 Future Outlook: Research Conclusion 129
17.1 Global Lyme Disease Diagnostic Market Outlook, 2021 & 2028: Future Outlook 129
17.2 Conclusion 130
List of Tables
TABLE 1 Global Lyme Disease Diagnostic Market Revenue by Diagnostic Technology, 2015 - 2028 (USD Million) 34
TABLE 2 Global Lyme Disease Diagnostic Market Revenue, by Serological test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 37
TABLE 3 Global Lyme Disease Diagnostic Market Revenue, by Lymphocytic transformation test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 40
TABLE 4 Global Lyme Disease Diagnostic Market Revenue, by Urine Antigen Testing, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 43
TABLE 5 Global Lyme Disease Diagnostic Market Revenue, by Immunofluorescent staining, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 46
TABLE 6 Global Lyme Disease Diagnostic Market Revenue, by Nucleic acid test, By Diagnostic Technology, by Region, 2015-2028 (USD Million) 49
TABLE 7 Global Lyme Disease Diagnostic Market Revenue By End User, 2015 - 2028 (USD Million) 51
TABLE 8 Global Lyme Disease Diagnostic Market Revenue, by Hospitals, By End User, by Region, 2015-2028 (USD Million) 54
TABLE 9 Global Lyme Disease Diagnostic Market Revenue, by Clinical Laboratories, By End User, by Region, 2015-2028 (USD Million) 57
TABLE 10 Global Lyme Disease Diagnostic Market Revenue, By Geographic Regions, 2015 - 2028 (USD Million) 59
TABLE 11 North America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 62
TABLE 12 North America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 62
TABLE 13 North America Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 64
TABLE 14 US Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 65
TABLE 15 US Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 65
TABLE 16 Canada Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 66
TABLE 17 Canada Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 66
TABLE 18 Mexico Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 67
TABLE 19 Mexico Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 67
TABLE 20 Europe Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 70
TABLE 21 Europe Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 70
TABLE 22 Europe Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 72
TABLE 23 Germany Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 73
TABLE 24 Germany Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 73
TABLE 25 UK Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 74
TABLE 26 UK Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 74
TABLE 27 France Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 75
TABLE 28 France Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 75
TABLE 29 Italy Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 76
TABLE 30 Italy Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 76
TABLE 31 Spain Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 77
TABLE 32 Spain Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 77
TABLE 33 Rest of Europe Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 78
TABLE 34 Rest of Europe Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 78
TABLE 35 Asia Pacific Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 81
TABLE 36 Asia Pacific Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 81
TABLE 37 Asia Pacific Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 83
TABLE 38 China Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 84
TABLE 39 China Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 84
TABLE 40 India Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 85
TABLE 41 India Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 85
TABLE 42 Japan Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 86
TABLE 43 Japan Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 86
TABLE 44 South Korea Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 87
TABLE 45 South Korea Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 87
TABLE 46 Rest of Asia-Pacific Lyme Disease Diagnostic Market Revenue Overview, By Diagnostic Technology, 2015 - 2028 (USD Million) 88
TABLE 47 Rest of Asia-Pacific Lyme Disease Diagnostic Market Revenue Overview, By End User, 2015 - 2028 (USD Million) 88
TABLE 48 Middle East & Africa Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 91
TABLE 49 Middle East & Africa Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 91
TABLE 50 Middle East & Africa Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 93
TABLE 51 GCC Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 94
TABLE 52 GCC Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 94
TABLE 53 South Africa Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 95
TABLE 54 South Africa Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 95
TABLE 55 ROMEA Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 96
TABLE 56 ROMEA Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 96
TABLE 57 South America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 99
TABLE 58 South America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 99
TABLE 59 South America Lyme Disease Diagnostic Market Revenue Overview, By Countries, 2015 - 2028 (USD Million) 101
TABLE 60 Brazil Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 102
TABLE 61 Brazil Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 102
TABLE 62 Argentina Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 103
TABLE 63 Argentina Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 103
TABLE 64 Rest of South America Lyme Disease Diagnostic Market Revenue, By Diagnostic Technology, 2015 - 2028 (USD Million) 104
TABLE 65 Rest of South America Lyme Disease Diagnostic Market Revenue, By End User, 2015 - 2028 (USD Million) 104
TABLE 66 Bio-Rad Laboratories: Company Profile. 107
TABLE 67 T2 Biosystems: Company Profile. 110
TABLE 68 Oxford Immunotec: Company Profile. 113
TABLE 69 Roche Diagnostics International Ltd: Company Profile. 115
T
The Leading Key Players in Lyme Disease Diagnostic Market
